AGONOX, INC.

Follow

Organization

PORTLAND, OR, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Utilization of CD39 and CD103 for identification of human tumor rea...
- Patent number 11,572,541
- Issue date Feb 7, 2023
- PROVIDENCE HEALTH & SERVICES-OREGON
- Andrew D. Weinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CXCR5, PD-1, AND ICOS EXPRESSING TUMOR REACTIVE CD4 T CELLS AND THE...
- Publication number 20240277842
- Publication date Aug 22, 2024
- Providence Health & Services - Oregon
- Andrew D. Weinberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
UTILIZATION OF CD39 AND CD103 FOR IDENTIFICATION OF HUMAN TUMOR REA...
- Publication number 20230220340
- Publication date Jul 13, 2023
- Providence Health & Services - Oregon
- Andrew D. Weinberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Anti-CD55 Antibodies and Related Compositions and Methods
- Publication number 20220088193
- Publication date Mar 24, 2022
- AgonOx, Inc.
- Ryan D. Montler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD55-Binding Agent-Related Methods and Compositions
- Publication number 20210070858
- Publication date Mar 11, 2021
- AgonOx, Inc.
- Ryan D. Montler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
UTILIZATION OF CD39 AND CD103 FOR IDENTIFICATION OF HUMAN TUMOR REA...
- Publication number 20200149008
- Publication date May 14, 2020
- Providence Health & Services - Oregon
- Andrew D. Weinberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Trademarklast 30 trademarks